Investor Presentation on Scheme of Amalgamation
M&A
◆ Monitor Closely
MEDIUM RISK
📅 Filed on BSE: 06 Apr 2026, 12:03 PM IST · BSE ID: 3666167d-829b-449b-a270-24ea4acb3a7e
View Original BSE Filing (PDF)
💡
In Simple Terms
The company is merging two of its subsidiary companies into itself to simplify operations, cut duplicate costs, and strengthen its market position as one unified brand.
🤖 AI Summary
- Board approves amalgamation of Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited into parent MOL
- No new shares issued — shareholding pattern remains 51.02% public, 48.98% promoters post-amalgamation
- Assets and liabilities transfer at book value under Pooling of Interest Method (Ind AS 103)
- Consolidates crop protection, crop nutrition, pigments and TiO2 operations into single listed entity
- Pending NCLT approval and shareholder consent; effective date January 1, 2026
🔢 Key Numbers — exact figures from BSE filing, not rounded
Public shareholding (as of 31 December 2025)
51.02%
Promoter shareholding (as of 31 December 2025)
48.98%
Number of subsidiaries amalgamating
2 (Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited)
New shares to be issued
None
🏢 How This Affects the Company
Consolidates crop protection, crop nutrition, pigments and TiO2 product lines under single operational and brand entity. Eliminates duplicate sales, marketing and R&D functions across subsidiaries.
No cash consideration issued; balance sheet consolidation via book value transfer. Eliminates inter-company balances and duplicate compliances. Carries forward losses and depreciation of transferor companies.
All employees of Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited transfer to MOL without break. Eliminates duplicate governance, compliance and administrative overhead across three legal entities.
Regulatory risk: scheme requires NCLT approval and shareholder consent — delays or rejection would stall integration. Integration execution risk across three currently separate operations and systems.
👥 What This Means For Shareholders
✅
Action Required
Monitor shareholder meeting notice for vote on amalgamation scheme; attendance/voting confirmation required before record date.
👤
Who Is Affected
All shareholders of Meghmani Organics Limited. Shareholding percentage remains unchanged at 51.02% public and 48.98% promoters post-completion. No share issuance or dilution occurs.
🔍
Management Signal
Management prioritizes organizational simplification and operational efficiency over growth-via-acquisition. Focus on internal consolidation and cost rationalization.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Shareholder meeting notice and voting record date — confirms regulatory timeline progression.
NCLT approval filing — critical gating event; watch for Regulation 37 disclosure.
Post-amalgamation financial statements and revised tax returns — validate integration completion and asset consolidation.
MEDIUM RISK
NCLT and shareholder approvals are binary gates — rejection or significant delay halts integration. Integration complexity across three separate operations poses execution risk.
💡 Investor Takeaway
Board approved amalgamation of two wholly-owned subsidiaries into Meghmani Organics on April 4, 2026. Shareholding structure unchanged at 51.02% public, 48.98% promoters. No new shares issued. Pending NCLT approval and shareholder consent—completion date and regulatory timeline not disclosed.
⚖️ Strengths & Concerns
✅ Positives
- Eliminates duplicate governance and compliance costs by maintaining single legal entity structure.
- Transfers all assets, liabilities, licenses and permits on going concern basis without operational disruption.
⚠️ Concerns
- Amalgamation pending NCLT approval and shareholder consent — no timeline confirmed, completion uncertain.
- Integration of three separate operations carries execution complexity and operational disruption risk.